NYSEARCA:IVOGVanguard S&P Mid-Cap 400 Growth ETF Stock Price, Forecast & News

Vanguard S&P Mid-Cap 400 Growth ETF's stock was trading at $118.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IVOG shares have increased by 28.5% and is now trading at $152.78.
View which stocks have been most impacted by Coronavirus.

Vanguard S&P Mid-Cap 400 Growth ETF announced an annual dividend on Monday, December 16th. Stockholders of record on Tuesday, December 17th will be paid a dividend of $1.7219 per share on Thursday, December 19th. This represents a dividend yield of 1.2%. The ex-dividend date of this dividend is Monday, December 16th. This is a positive change from Vanguard S&P Mid-Cap 400 Growth ETF's previous annual dividend of $1.19.
View Vanguard S&P Mid-Cap 400 Growth ETF's dividend history.

Media stories about IVOG stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vanguard S&P Mid-Cap 400 Growth ETF earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.
View the latest news about Vanguard S&P Mid-Cap 400 Growth ETF.

Based on aggregate information from My MarketBeat watchlists, some companies that other Vanguard S&P Mid-Cap 400 Growth ETF investors own include BlackRock Science & Technology Trust (BST), SPDR Gold Shares (GLD), Johnson & Johnson (JNJ), Adobe (ADBE), CNX Midstream Partners (CNXM), Lam Research (LRCX), Lululemon Athletica (LULU), Mastercard (MA), Netflix (NFLX) and SPDR S&P 500 ETF Trust (SPY).

Vanguard S&P Mid-Cap 400 Growth ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IVOG."

Vanguard S&P Mid-Cap 400 Growth ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Stordahl Capital Management Inc. (1.23%), Raymond James Financial Services Advisors Inc. (0.63%), UBS Group AG (0.60%), Envestnet Asset Management Inc. (0.47%), Adviser Investments LLC (0.38%) and Relaxing Retirement Coach (0.33%).

IVOG stock was sold by a variety of institutional investors in the last quarter, including Stordahl Capital Management Inc., PNC Financial Services Group Inc., Relaxing Retirement Coach, Sawtooth Solutions LLC, Cambridge Investment Research Advisors Inc., and Trellis Advisors LLC.

IVOG stock was bought by a variety of institutional investors in the last quarter, including Raymond James Financial Services Advisors Inc., Gateway Advisory LLC, Envestnet Asset Management Inc., Adviser Investments LLC, Meridian Wealth Management LLC, and UBS Group AG.

Shares of IVOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IVOG stock can currently be purchased for approximately $152.78.

Vanguard S&P Mid-Cap 400 Growth ETF has a market capitalization of $737.16 million.